Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma —a retrospective, international, multicentric AGEO study
ConclusionNo additional benefit of adding F to T monotherapy as a maintenance treatment could be observed. Reintroduction of initial therapy at first progression may be a feasible approach to preserve later treatment lines.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Academia | Adenocarcinoma | Austria Health | Cancer | Cancer & Oncology | Chemotherapy | France Health | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin | Italy Health | Study